Ove Almkvist

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Cognitive support at episodic encoding and retrieval: similar patterns of utilization in community-based samples of Alzheimer's disease and vascular dementia patients
    O Almkvist
    Stockholm Gerontology Research Center, Sweden
    J Clin Exp Neuropsychol 21:816-30. 1999
  2. ncbi Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients
    O Almkvist
    Neurotec Department, Karolinska Institutet, Stockholm, Sweden
    Eur J Neurol 11:253-61. 2004
  3. ncbi Estimation of premorbid cognitive function based on word knowledge: the Swedish Lexical Decision Test (SLDT)
    O Almkvist
    Department of Psychology, Stockholm University, Sweden
    Scand J Psychol 48:271-9. 2007
  4. ncbi Cognitive syndrome(s) in preclinical and clinical vascular dementia
    Ove Almkvist
    Karolinska Institutet, Stockholm, Sweden
    Int Psychogeriatr 15:127-31. 2003
  5. ncbi Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease
    Eva Arnaiz
    Karolinska Institutet, Department of Clinical Neuroscience, Occupational Therapy, and Elderly Care Research NEUROTEC, Division of Geriatric Medicine, Huddinge University Hospital, Huddinge, Sweden
    Acta Neurol Scand Suppl 179:34-41. 2003
  6. ncbi Functional brain imaging as a looking-glass into the degraded brain: reviewing evidence from Alzheimer disease in relation to normal aging
    O Almkvist
    Neurotec, Geriatric Medicine, Huddinge University Hospital, and Queen Sophia University College of Nursing, 14186 Huddinge, Stockholm, Sweden
    Acta Psychol (Amst) 105:255-77. 2000
  7. ncbi Early diagnosis of Alzheimer dementia based on clinical and biological factors
    O Almkvist
    Division of Geriatric Medicine, Huddinge University Hospital, Sweden
    Eur Arch Psychiatry Clin Neurosci 249:3-9. 1999
  8. ncbi Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
    Christin Andersson
    Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, NOVUM Karolinska University Hospital Huddinge, S 141 86 Stockholm, Sweden
    Neurobiol Aging 29:1466-73. 2008
  9. ncbi Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
    Michael Scholl
    Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden
    Neurology 79:229-36. 2012
  10. ncbi Failure to modulate neural response to increased task demand in mild Alzheimer's disease: fMRI study of visuospatial processing
    Patrizia Vannini
    Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Neurobiol Dis 31:287-97. 2008

Collaborators

Detail Information

Publications49

  1. ncbi Cognitive support at episodic encoding and retrieval: similar patterns of utilization in community-based samples of Alzheimer's disease and vascular dementia patients
    O Almkvist
    Stockholm Gerontology Research Center, Sweden
    J Clin Exp Neuropsychol 21:816-30. 1999
    ..The results suggests a similarity between AD and VaD patients with regard to the nature of the episodic memory impairment, despite etiologic differences between the diseases...
  2. ncbi Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients
    O Almkvist
    Neurotec Department, Karolinska Institutet, Stockholm, Sweden
    Eur J Neurol 11:253-61. 2004
    ..In conclusion, a clear beneficial effect of rivastigmine was shown on cognitive function for patients with mild AD and plasma values of ChE inhibition were associated with attention...
  3. ncbi Estimation of premorbid cognitive function based on word knowledge: the Swedish Lexical Decision Test (SLDT)
    O Almkvist
    Department of Psychology, Stockholm University, Sweden
    Scand J Psychol 48:271-9. 2007
    ..Finally, the theoretical foundation for the relationship between word knowledge and global cognitive function is discussed...
  4. ncbi Cognitive syndrome(s) in preclinical and clinical vascular dementia
    Ove Almkvist
    Karolinska Institutet, Stockholm, Sweden
    Int Psychogeriatr 15:127-31. 2003
    ..To summarize characteristics during preclinical and clinical stages, VaD appears to be associated with impairment in motor and mental speed as well as in executive function...
  5. ncbi Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease
    Eva Arnaiz
    Karolinska Institutet, Department of Clinical Neuroscience, Occupational Therapy, and Elderly Care Research NEUROTEC, Division of Geriatric Medicine, Huddinge University Hospital, Huddinge, Sweden
    Acta Neurol Scand Suppl 179:34-41. 2003
    ..Recommendations concerning methodological issues and the early management of neuropsychological MCI studies were made...
  6. ncbi Functional brain imaging as a looking-glass into the degraded brain: reviewing evidence from Alzheimer disease in relation to normal aging
    O Almkvist
    Neurotec, Geriatric Medicine, Huddinge University Hospital, and Queen Sophia University College of Nursing, 14186 Huddinge, Stockholm, Sweden
    Acta Psychol (Amst) 105:255-77. 2000
    ..In conclusion, the pattern of activation in AD depends on interactions between the clinical stage of patients, and the pattern of brain degeneration, as well as the task difficulty and specific networks necessary for solving the task...
  7. ncbi Early diagnosis of Alzheimer dementia based on clinical and biological factors
    O Almkvist
    Division of Geriatric Medicine, Huddinge University Hospital, Sweden
    Eur Arch Psychiatry Clin Neurosci 249:3-9. 1999
    ..It is concluded that still no single marker of AD exists, which makes it necessary to rely on data from multiple sources in order to arrive at the best possible diagnosis of AD...
  8. ncbi Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
    Christin Andersson
    Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, NOVUM Karolinska University Hospital Huddinge, S 141 86 Stockholm, Sweden
    Neurobiol Aging 29:1466-73. 2008
    ..Little is known about longitudinal changes of cerebrospinal fluid (CSF) biomarkers during cognitive decline in neurodegenerative disease progression...
  9. ncbi Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
    Michael Scholl
    Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden
    Neurology 79:229-36. 2012
    ..To investigate the particular pathology of the Arctic APP (APParc) early-onset familial Alzheimer disease (eoFAD) mutation for the first time in vivo with PET in comparison with other eoFAD mutations and sporadic Alzheimer disease (sAD)...
  10. ncbi Failure to modulate neural response to increased task demand in mild Alzheimer's disease: fMRI study of visuospatial processing
    Patrizia Vannini
    Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Neurobiol Dis 31:287-97. 2008
    ..These results confirm deficits in visuospatial abilities, which occur early in AD, and offer new insights into the neural mechanisms underlying this impairment...
  11. ncbi Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease
    Hans Basun
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden
    Arch Neurol 65:499-505. 2008
    ..Most of these mutations may also cause cognitive impairment, but the Arctic APP mutation is the only known intra-beta-amyloid mutation to date causing the more typical clinical picture of Alzheimer disease...
  12. ncbi Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment
    Christin Andersson
    Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Dement Geriatr Cogn Disord 23:87-95. 2007
    ..To investigate the relationships between episodic memory, APOE genotype, CSF markers (total tau, T-tau; phospho-tau, P-tau; beta-amyloid, Abeta42) and longitudinal cognitive decline...
  13. ncbi Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers
    Michael Scholl
    Department of Neurobiology, Care Sciences and Society, Division of Alzheimer Neurobiology, Karolinska Institutet, Stockholm, Sweden
    J Alzheimers Dis 24:495-506. 2011
    ..We here show that FDG PET can depict in vivo the aggressive disease progression in eoFAD mutation carriers in relationship to neuropathology...
  14. ncbi Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease
    Ahmadul Kadir
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Neurobiol Aging 33:198.e1-14. 2012
    ..The rCMRglc starts to decline in MCI patients and became more pronounced in clinical stage which related to continuous decline in cognition...
  15. ncbi PET imaging of amyloid deposition in patients with mild cognitive impairment
    Anton Forsberg
    Karolinska Institute, Department of Neurobiology, Care Sciences and Society, Stockholm, Sweden
    Neurobiol Aging 29:1456-65. 2008
    ..01). The PIB retention in MCI converters was comparable to AD patients (p>0.01). Correlations were observed in the MCI patients between PIB retention and CSF Abeta(1-42), total Tau and episodic memory, respectively...
  16. ncbi Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease
    Maria Eriksdotter-Jonhagen
    Departments of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Stockholm, Sweden maria eriksdotter jonhagen ki se
    Dement Geriatr Cogn Disord 33:18-28. 2012
    ..Here we report the results of a first-in-man study of encapsulated cell (EC) biodelivery of NGF to the basal forebrain of AD patients with the primary objective to explore safety and tolerability...
  17. ncbi Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET
    Ahmadul Kadir
    Karolinska Institute, Department of Neurobiology, Care Sciences and Society, Division of Molecular Neuropharmacology, Karolinska University Hospital Huddinge, Novum floor 5, 141 86, Stockholm, Sweden
    Psychopharmacology (Berl) 191:1005-14. 2007
    ..Thus, we used positron emission tomography (PET) technique as a sensitive approach to assess longitudinal changes in the nicotine binding sites in the brains of patients with AD...
  18. ncbi Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo
    Taher Darreh-Shori
    Department of Neurobiology, Care Sciences and Society, Division of Alzheimer Neurobiology, Karolinska Institutet, Stockholm, Sweden
    Neurobiol Aging 32:2320.e15-32. 2011
    ....
  19. ncbi Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation
    Michael Scholl
    Division of Alzheimer Neurobiology, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
    Neurobiol Aging 32:1388-99. 2011
    ..Global cortical CMRglc and cognition were distinctly decreased. PIB binding was comparable with sporadic AD patterns but showing slightly higher striatal levels...
  20. ncbi Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease
    Ahmadul Kadir
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Sweden
    Ann Neurol 63:621-31. 2008
    ....
  21. ncbi Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial processing
    Patrizia Vannini
    Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics, Karolinska Institutet, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden
    Psychiatry Res 156:43-57. 2007
    ..Increased parietal activation in PMCI could reflect a reduced neuronal efficacy due to accumulating AD pathology and might predict future clinical decline in patients with MCI...
  22. ncbi Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG
    Stephen F Carter
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
    J Nucl Med 53:37-46. 2012
    ..Along with (11)C-DED PET, (11)C-Pittsburgh compound B ((11)C-PIB; fibrillar Aβ deposition), (18)F-FDG (glucose metabolism), T1 MRI, cerebrospinal fluid, and neuropsychologic data were acquired from the patients...
  23. ncbi Cognitive decline from estimated premorbid status predicts neurodegeneration in Alzheimer's disease
    Ove Almkvist
    Department of Psychology, Stockholm University, Stockholm, Sweden
    Neuropsychology 23:117-24. 2009
    ..g., SLDT and ISW) were insensitive to AD and that these abilities indicated premorbid cognitive function in retrospect. In conclusion, cognitive decline from premorbid status reflects the disease processes...
  24. ncbi Self- and informant ratings of personality in mild cognitive impairment, reviewed
    Birgitta Ausén
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
    Dement Geriatr Cogn Disord 32:387-93. 2011
    ..To examine the degree of agreement between self- and informant ratings of personality in relation to cognitive function in patients with mild cognitive impairment (MCI), subjective cognitive impairment (SCI) and healthy controls (HC)...
  25. ncbi The importance of impaired physical health and age in normal cognitive aging
    Ingvar Bergman
    Neurotec Department, Karolinska Institutet, Karolinska University Hospital, Huddinge, Sweden
    Scand J Psychol 48:115-25. 2007
    ..Because the prevalent diseases in normal aging are potentially preventable, the present findings promise good prospect for prevention of future cognitive disability among elderly people...
  26. ncbi Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease
    Ahmadul Kadir
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Brain 134:301-17. 2011
    ....
  27. ncbi Personality features in subjective cognitive impairment and mild cognitive impairment--early indicators of dementia?
    Birgitta Ausén
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm University, Stockholm, Sweden
    Dement Geriatr Cogn Disord 28:528-35. 2009
    ..The purpose of the present study was to investigate patterns of personality in patients with subjective cognitive impairment (SCI) and mild cognitive impairment (MCI), compared to healthy controls...
  28. ncbi Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairment
    Ove Almkvist
    Division of Clinical Geriatrics and Experimental Geriatrics, Department of Neurotec, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
    Acta Neurol Scand Suppl 179:77-82. 2003
    ..In conclusion, clinical examinations of relatively young individuals carrying an AD mutation did not reveal any marked abnormalities before the clinical onset of dementia...
  29. ncbi Phonemic fluency deficits in asymptomatic gene carriers for Huntington's disease
    Maria U Larsson
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stoskholm, Sweden
    Neuropsychology 22:596-605. 2008
    ....
  30. ncbi Early cognitive impairment in a subset of patients with presumed low-grade glioma
    Lena Ek
    Department of Psychology, Stockholm University, Stockholm, Sweden
    Neurocase 16:503-11. 2010
    ..We conclude that cognitive dysfunction may be present already at early stage of disease, and that early identification of patients at risk is warranted...
  31. ncbi Task demand modulations of visuospatial processing measured with functional magnetic resonance imaging
    Patrizia Vannini
    Division of Clinical Geriatrics, Neurotec Department, Karolinska Institutet, Huddinge University Hospital, 14186, Stockholm, Sweden
    Neuroimage 21:58-68. 2004
    ..The brain regions that are most specialized for the execution of the visuospatial task can be assessed by relating the imposed task demand to the functional activation measured...
  32. ncbi Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup
    Lars Olof Wahlund
    Department of Neurobiology, Caring Sciences and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden
    Top Magn Reson Imaging 16:427-37. 2005
    ..A great interest has been put in whether atrophy in the medial temporal lobe can serve as an early diagnostic marker for Alzheimer disease...
  33. ncbi Insidious cognitive decline in CADASIL
    Kaarina Amberla
    Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden
    Stroke 35:1598-602. 2004
    ..CONCLUSIONS: A deterioration of working memory and executive function was already observed in the prestroke phase, which means that cognitive decline may start insidiously before the first onset of symptomatic ischemic episodes...
  34. ncbi PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease
    Ahmadul Kadir
    Department of Neurobiology, Care Sciences and Society, Division of Molecular Neuropharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Novum Floor-5, Stockholm, 141 86, Sweden
    Psychopharmacology (Berl) 188:509-20. 2006
    ..CONCLUSION: Cortical nicotinic receptors in vivo in mild AD patients are robustly associated with the cognitive function of attention...
  35. ncbi The assessment of fitness to drive after a stroke: the Nordic Stroke Driver Screening Assessment
    Catarina Lundberg
    Karolinska Institutet, Stockholm, Sweden
    Scand J Psychol 44:23-30. 2003
    ..We conclude that the Nordic version of the SDSA is a useful instrument, provided that test scores are interpreted in a balanced manner, taking into account the possibility of compensatory traffic behavior...
  36. ncbi Cognitive functioning in Alzheimer's disease and vascular dementia: further evidence for similar patterns of deficits
    Kjell Fahlander
    Stockholm Gerontology Research Center and NEUROTEC, Division of Geriatric Epidemiology, Karolinska Institute, Stockholm, Sweden
    J Clin Exp Neuropsychol 24:734-44. 2002
    ..These findings suggest that AD and AD may affect several basic cognitive functions in an equal manner...
  37. ncbi Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients
    Christin Andersson
    Neurotec Department, Division of Clinical Geriatrics, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Dement Geriatr Cogn Disord 21:251-9. 2006
    ..To investigate whether application of cutoff levels in an episodic memory test (Rey Auditory Verbal Learning Test, RAVLT) is a useful method for identifying patients at high and low risk of cognitive decline and subsequent dementia...
  38. ncbi Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment
    Chaorui Huang
    Department of Clinical Neuroscience, Occupational Therapy and Elderly Care Research, Division of Geriatric Medicine, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
    Neuroimage 19:1137-44. 2003
    ..Combined SPECT investigation and neuropsychological testing might predict the future development of dementia in patients with MCI...
  39. ncbi Combination of (18)F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients
    Il Han Choo
    Alzheimer Neurobiology Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
    J Alzheimers Dis 33:929-39. 2013
    ..In conclusion, our findings highlight that the combination of regional glucose metabolic assessment by PET and CSF biomarkers evaluation can significantly improve AD predictive diagnostic accuracy of each respective method...
  40. ncbi A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
    Agneta Nordberg
    Alzheimer Neurobiology Centre, Geriatric Clinic, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Eur J Nucl Med Mol Imaging 40:104-14. 2013
    ..To serve as an early biomarker in AD the amyloid PET tracers need to be analysed in multicentre clinical studies...
  41. ncbi Individual variability and environmental characteristics influence older adults' abilities to manage everyday technology
    Camilla Malinowsky
    Department of Neurobiology, Care Sciences and Society, Division of Occupational Therapy, Karolinska Institutet, Stockholm, Sweden
    Int Psychogeriatr 24:484-95. 2012
    ..This study aimed to identify aspects that influence the ability to manage ET among older adults with and without cognitive impairment...
  42. ncbi Life situation, coping and quality of life in people with high and low risk of developing Alzheimer's disease
    Karin Axelman
    Institution NEUROTEC, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
    Dement Geriatr Cogn Disord 16:220-8. 2003
    ..About 50% of the respondents complained about a lack of information. The pieces of information they asked for were early signs of the disease, treatment, and practical information on how to handle everyday life with an affected relative...
  43. ncbi Word fluency performance and strategies in children with cochlear implants: age-dependent effects?
    Ulrika Löfkvist
    Department of Speech and Language Pathology, Cochlear Implant Section, Karolinska University Hospital, Stockholm, Sweden
    Scand J Psychol 53:467-74. 2012
    ..The results are discussed with respect to factors such as age differences in performance for children with CI, especially for the phonemically based task...
  44. ncbi Semantic range and relevance of emotive utterances in patients with frontotemporal degeneration
    Ing Mari Tallberg
    Department of Logopedics, Division of Geriatric Medicine, Karolinska Institutet, Huddinge University Hospital, SE 14186 Huddinge, Sweden
    Brain Lang 82:146-58. 2002
    ..The results are discussed in terms of impaired semantic retrieval and in relation to lateralization of lesion...
  45. ncbi [Cognitive impairment after stroke--diagnosis and management]
    Torgeir Engstad
    Geriatrisk avdeling, Universitetssykehuset Nord Norge, 9038 Tromsø
    Tidsskr Nor Laegeforen 127:1390-3. 2007
    ..An incidence of stroke is often followed by cognitive impairment. This review article presents an update about such impairment and emphasises diagnostical and therapeutical challenges...
  46. ncbi Impaired motor speed, visuospatial episodic memory and verbal fluency characterize cognition in long-term stroke survivors: the Tromsø Study
    Torgeir Engstad
    Institute of Community Medicine, University of Tromsø, Norway
    Neuroepidemiology 22:326-31. 2003
    ..This pattern of cognitive disturbances may be a consequence of cerebral lesions in frontal subcortical areas, and is different from Alzheimer's disease...
  47. ncbi Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
    Henry Engler
    Uppsala Imanet AB, Imanet, GE Healthcare Uppsala University, Uppsala
    Brain 129:2856-66. 2006
    ..FDG imaging may be able to detect a stabilization of cerebral metabolism caused by therapy administered to patients with a clinical diagnosis of Alzheimer's disease...
  48. ncbi Reading words with irregular decoding rules: a test of premorbid cognitive function?
    Ing Mari Tallberg
    CLINTEC Department, Division of Logopedics and Phoniatrics, Karolinska Insitutet, Sweden
    Scand J Psychol 47:531-9. 2006
    ..Exposure to written and spoken vocabulary during the lifespan may be indexed by ISW performance, for factor analysis suggested that this may constitute a discrete factor contributing to cognitive function...
  49. ncbi Increased sensitivity in mapping task demand in visuospatial processing using reaction-time-dependent hemodynamic response predictors in rapid event-related fMRI
    Christoph Lehmann
    Department of Psychiatric Neurophysiology, University Hospital of Clinical Psychiatry, Waldau, CH-3000 Bern 60, Switzerland
    Neuroimage 31:505-12. 2006
    ....